Topic

Nymox Pharmaceutical

A collection of 2 issues

Nymox Pharmaceutical Corp. Posts Q3 Loss of $716,000

Nymox Pharmaceutical Corp. reports a Q3 loss of $716,000, equivalent to 1 cent per share. Discover the financial performance and insights into the company's future.

Nymox Pharmaceutical Corp. Faces $716,000 Loss in Q3

Nymox Pharmaceutical Corp. announces a Q3 loss of $716,000, highlighting challenges in the pharmaceutical sector. Explore the financial implications.